Comparison of healthcare costs and resource utilization for overactive bladder patients in the United States persisting with mirabegron treatment or switching to onabotulinumtoxin A
NEUROUROLOGY AND URODYNAMICS（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要